Your browser doesn't support javascript.
loading
Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy.
Jayaprakash, Priyamvada; Ai, Midan; Liu, Arthur; Budhani, Pratha; Bartkowiak, Todd; Sheng, Jie; Ager, Casey; Nicholas, Courtney; Jaiswal, Ashvin R; Sun, Yanqiu; Shah, Krishna; Balasubramanyam, Sadhana; Li, Nan; Wang, Guocan; Ning, Jing; Zal, Anna; Zal, Tomasz; Curran, Michael A.
Afiliación
  • Jayaprakash P; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ai M; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Liu A; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Budhani P; University of Texas Health Science Center at Houston Graduate School of Biomedical Science, Houston, Texas, USA.
  • Bartkowiak T; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Sheng J; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ager C; University of Texas Health Science Center at Houston Graduate School of Biomedical Science, Houston, Texas, USA.
  • Nicholas C; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Jaiswal AR; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Sun Y; University of Texas Health Science Center at Houston Graduate School of Biomedical Science, Houston, Texas, USA.
  • Shah K; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Balasubramanyam S; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Li N; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Wang G; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ning J; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Zal A; Department of Biostatistics and.
  • Zal T; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Curran MA; Department of Biostatistics and.
J Clin Invest ; 128(11): 5137-5149, 2018 11 01.
Article en En | MEDLINE | ID: mdl-30188869
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mostazas de Fosforamida / Neoplasias de la Próstata / Linfocitos T / Adenocarcinoma / Inmunoterapia / Neoplasias Experimentales / Nitroimidazoles Límite: Animals Idioma: En Revista: J Clin Invest Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mostazas de Fosforamida / Neoplasias de la Próstata / Linfocitos T / Adenocarcinoma / Inmunoterapia / Neoplasias Experimentales / Nitroimidazoles Límite: Animals Idioma: En Revista: J Clin Invest Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos